Endpoints News Jun 2, 2026 Cancer cases weigh down Abivax’s Phase 3 maintenance data in ulcerative colitis
Endpoints News Jun 2, 2026 Praxis sinks on late-stage study fail for seizure pill, halts second trial
Endpoints News Jun 2, 2026 Allen Institute launches $200M effort to turn brain atlas lessons into medicines
Endpoints News Jun 1, 2026 The cost of a PRV is twice as high as it was three years ago — and it’s likely to stay that way
Endpoints News Jun 1, 2026 Shionogi wins US approval for first pill to prevent Covid following exposure
Endpoints News Jun 1, 2026 After being ditched by Candid, Rallybio finds Avenzo to take its Nasdaq listing
Endpoints News Jun 1, 2026 Servier signs $1.55B upfront deal for Edgewise's muscular dystrophy assets
Endpoints News Jun 1, 2026 #ASCO26: Erleada succeeds in early-stage prostate cancer study, but questions remain